申请人:Miyaji Katsuaki
公开号:US20090198060A1
公开(公告)日:2009-08-06
Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided.
A compound represented by the formula (I) (wherein R
1
, R
2
, R
3
, L
1
, L
2
, L
3
, X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
本发明提供了一种有效预防、治疗或改善激活血小板生成素受体有效的疾病的化合物。其中化合物由公式(I)表示(其中R1、R2、R3、L1、L2、L3、X和Y在说明中定义),该化合物的互变异构体、前药或药学上可接受的盐或其溶剂化物。